… proprietary multiple sclerosis drug Copaxone (glatiramer acetate). … doctors and organizations involved in drug … pharmaceutical sector” and its contribution to keeping drugs affordable, preserving choice of treatment … writing for medical professionals and …

… European Commission fined the Israeli pharmaceutical group Teva 426.6 million … dominant position” for its drug against multiple sclerosis, Copaxone. The Israeli company … also sells its own drugs such as Copaxone. About two weeks ago …

… ($502m) on Teva Pharmaceuticals Industries after investigating the … of-care multiple sclerosis treatment, Copaxone. The fine relates … approval. This campaign targeted doctors and national decision-makers … expressed deep disappointment stating that it has …

… lower-cost generic versions of Copaxone (glatiramer acetate), whose last … efficacy, and therapeutic equivalence with Copaxone. The net result was that … contributes to keeping drugs affordable, preserving choice of treatment and fostering innovation …

… Commission fined Israeli drugmaker Teva Pharmaceuticals over 460 million … for its multiple sclerosis drug Copaxone and undermining a … targeted doctors and groups involved in drug pricing … drug pravastatin, a generic version of the brand-name medicine …

… its blockbuster multiple sclerosis medicine. Teva said it … protection" of its drug Copaxone and "systematically … competition enforcement in the pharmaceutical sector," EU … to keeping drugs affordable, preserving choice of treatment and …

… work on a similar treatment. Teva said it planned … The European Commission said the pharmaceutical firm "misused the … ; for its blockbuster MS drug Copaxone, whose active ingredient is … campaigns to foreclose competing medicines," said EU antitrust …

… of a competing medicine. The commission said the pharmaceutical firm “misused the … protection” for its blockbuster MS drug Copaxone, whose active ingredient is glatiramer … Teva officials targeted doctors and groups involved in drug pricing and reimbursement …

… ” against a particular glatiramer acetate medication for MS by spreading misleading … to Copaxone. Teva allegedly targeted doctors and decision-makers for pricing and drug … the drugmaker beyond Europe as well. Earlier this month, Teva Pharmaceuticals USA …